Management of Dengue Viral Infection in Endemic Resource LimitedCountries
Abstract
Dengue fever is a common epidemic / endemic disease worldwide especially in under-developed countries and tropical areas. It has serious health, economical and epidemiological issues. If it's not managed properly, the mortality rate can be high. It's often confused with other acute infectious diseases such as chikungunya, malaria, typhoid and COVID. This diagnostic confusion is a big issue especially in resource limited countries where these are common, and sometimes these diseases can co-exist as well. These infectious diseases make a very difficult clinical puzzle that can mimic many other diseases as well and pose a great difficulty for the patient's management.As a result, many patients may be over treated for all these possibilities leading to antibiotic resistance, increased cost of treatment and prolonged illness. With proper management the mortality can be reduced. It's important to understand these diseases for managing patients with these infections, which almost every doctor see in clinical practice. This review article aims to provide insight into the pathogenesis of Dengue, its various manifestations, clinical approach for its differential diagnosis and its management considering recent evidence.
How to Cite This Article
Hussain A. Management of Dengue Viral Infection in Endemic Resource LimitedCountries. J Pak Soc Intern Med. 2023;4(3):193–200. doi:10.70302/jpsim.v4i3.2339
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Shepard DS, Undurraga EA, Halasa YA, et.al. The global economic burden of dengue: a systematic analysis. Lancet Infect. Dis. 2016: 16(8):935-41.
- Centres for Disease control & prevention. 2014. CDC- epidemiology-dengue. Available from: [http://www.cdc.gov/dengue/index.html].
- Bhatt S, Gethung PW, Brady OJ. The global distribution & burden of dengue. Nature. 2013: 496(6446):504-7.
- Byk LA, & Gamarnik AV. Properties & functions of the dengue virus capsid protein. Annu Rev Virol.2016; 3(2): 263-81.
- Carrington LB & Simmons CP. Human to mosquito transmission of dengue viruses. Front. Immunol.2014: doi: 10.3389/fimmu.2014.00290 doi:10.3389/fimmu.2014.00290
- Chao CH, Wu WC, Lai YC. Dengue virus NS-1 protein activates platelets via Toll-like receptor 4, leading to thrombocytopenia & haemorrhage. PLoS Pathog. 2019: 15(4): e1007625.
- Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus antibody dependent enhancement of infection upregulates the production of anti-inflammatory cytokines but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol. 2007: 88(2):365-373.
- Diamond MS, Pierson TC. Molecular insight into Dengue virus pathogenesis & it’s implications for disease control. Cell. 2015: 162(3):488-92.
- Bozza FA, Cruz OG, Zagre SM, et. Al. Multiple cytokine profile from dengue patients: MIP-1beta &IFN-gamma as predictive factors for severity. BMC infect. Dis. 2008: 8(1):86.
- Fisch W, Bartenschlager R. Exploitation of cellular pathway by Dengue virus. Curr. Opin. Microbiol.2011: 14(4):470-5.
- Kao YT, Lai M, Yu CY. How dengue virus circumvents innate immunity. Front Immunol. 2018; doi: 10.3389/fimmu.2018.02860. doi:10.3389/fimmu.2018.02860
- Rothman AL, Ennis FA. Immunopathogenesis of dengue haemorrhagic fever. Virology. 1999; 257(1): 1-6.
- Mueller,Dana, malaria & dengue fever, in Arjun S. Infectious disease emergencies, Emergencies New York. online edn. Oxford academic, 1 Nov. 2016.
- Parul D,S, Taay KM. Concurrent malaria & dengue infections among febrile patients. Indian J Microbiol. 2017: 35(3): 7-9.
- Arun KM, Nischal S, Sakar BG, Madhu S. Typhoid Fever among patients diagnosed with dengue fever in a tertiary care centre. A descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2022: 60(252):714-7.
- Amin Islam, Christopher C, Shereen E, Javeed A, Kevin J, et. al. Coagulopathy of Dengue & COVID-19: clinical considerations. Trop Med Infect Dis. 2022;7(9):210.
- Henrina J, Puttra ICS, Lawrensia S, Handoyono QF, Cahyadi A. Coronavirus disease. A mimicker of dengue infection? SN Compr Clin Med. 2020: (2) 1109-19.
- Centre for disease control & prevention (CDC). Is it a dengue or is it a COVID? Available online. [http://www.cdc.gov/dengue/healthcare-providers/dengue-or-covid.html].
- Waggoner JJ, Gresh L, Vargas MJ, Ballesteros G, Tellez Y, et al. Viremia & clinical presentation in Nicaraguan patients infected with Zika virus, chickengunya virus & dengue virus. Clin Infect Dis. 2016:63(6):1584-90.
- Potts JA, Rothmann AI: clinical & laboratory features that distinguish dengue from other febrile illnesses in endemic population. Trop Med Int Health. 2008:13(11):1328-40.
- Abhilash KPP, Jeevan JA, Mitra S, et al. Acute undifferentiated febrile illness in patients presenting to a tertiary care hospital in South India: clinical spectrum & outcome. J Global Infect. Dis. 2016;8(4):147-54.
- Jain V, Chopra A, Mir Ka, Babu C, Kohli S, Kapur P, Manjavkar S. Clinico-biochemical differences of patients presenting with dengue & chickengunya during post monsoon season. J Clin Diagn. Res. 2018;12(3): OC01-OC04.
- Shah I, Katira A. Clinical & laboratory profile of dengue, leptospirosis and malaria in children: a study from Mumbai. Arch Dis Child. 2007;92(6):561.
- Chrispal A, Boorugu H, Gopinath KG, et al. Acute undifferentiated febrile illness in adult hospitalised patients: the disease spectrum & diagnostic predictors-an experience from a tertiary care hospital in South India. Trop Doct. 2010;40(4):230-4.
- Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, et al. Evaluation of diagnostic tests: Dengue Nat Rev Microbiol. 2010;8(S1): S30-S37.
- WHO Dengue Guidelines for diagnosis, treatment, prevention & control: new edition available online. ISBN: 978 92 4 154787 1
- Kellstein D, Fernandes L. Symptomatic treatment of dengue. Should the NSAID contraindication be reconsidered? Postgrad. Med. 2019;131(1):109-16.
- Zapata JC, Cox D, Salvato MS. Role of platelets in the pathogenesis of viral haemorrhagic fevers. PLoS Negl Trop Dis. 2014;8(1):e2858.
- Rajapakse S; de Silva, NL, Weeratumga P, Rodrigo C, Fernando SD, et al. Prophylactic & therapeutic interventions for bleeding in Dengue: A systematic review. Trans R Soc Trop Med Hyg. 2017;111(3):433-9.
- Tayal A, Kabra SK, Lodhacorresponding R. Management of Dengue: An Updated Review. Indian J Pediatr. 2023; 90(2): 168–77.
- CDC-Guidelines for clinicians re: management of dengue fever. Available from: [https://www.cdc.gov/dengue/resources/dengue-clinician-guide_508.pdf]
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.